Last updated on August 2019

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)


Brief description of study

The aim of the study is to evaluate efficacy and safety of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with preserved ejection fraction

Clinical Study Identifier: NCT03057951

Find a site near you

Start Over

Kanmon Medical Center

Yamaguchi, Shimonoseki, Japan
3.59miles
  Connect »

Steel Memorial Yawata Hospital

Fukuoka, Kitakyushu, Japan
10.0miles
  Connect »